IHMRI affiliation

Theme:Chronic conditions and lifestyle

Research focus

  • Urology / stones
  • Medical devices
  • Cancer

Research projects

RELIEF II Study – A Prospective, Non-Randomised Multi-Centre Clinical Investigation of the Safety and Performance of GT Urological, LLC’s Phenix Device Artificial Urinary Sphincter. Investigator. Reference: UOW HREC Number: CT14/001. 2016 Clinical Trial of a new Artificial Urinary Sphincter.

Predicting risk of post-transrectal ultrasound prostate biopsy sepsis by categorising antibiotic resistance in bowel flora pre-transrectal ultrasound biopsy. Investigator. UOW HREC Number: HE13/217. The aim of this study is to investigate whether antibiotic resistant bowel flora cause a higher incidence of sepsis post-biopsy and whether a change in clinical practice and guidelines is indicated. Period: 2013 ongoing.

Safety and Feasibility of a Transurethral Endoscopic Procedure for the Luminal Restoration of the Prostatic Urethra: A Preliminary Investigation. Chief Investigator. Reference: UOW HREC Number: CT05/027. This is the first in human study for the Urolift device and is ongoing. Period: 2004 ongoing.

The LIFT Pivotal Study – Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms. Investigator. Reference: UOW HREC Number: CT10/09. Period: 2011 ongoing. This is a FDA approved randomised blinded multi-centre Phase 3 Pivotal trial. Recruitment is complete, and long term data is being monitored.

Publications and funding

  • Three Year durability after crossover to the Prostatic Urethral Lift from randomised, blinded sham. D.Bolton, P Rashid, P Chin, J Barkin, A Cantwell, W Bogache, S Richardson, R Tutrone, J Fagelson and HH Woo. BJU International 117, 2016 Supplement 3, 14
  • BPH6 trial two year results: the multi-national, prospective, randomized study of the Prostatic Urethral Lift (PUL) compared to transurethral resection of the prostate (TURP). C Gratzke, P Chin, N Barber, M Speakman, R Berges, U Wetterauer, K Sievert, C Chapple, L Fahrenkrug and J Sonksen. BJU International 117, 2016 Supplement 3, 17
  • Prospective,randomized, blinded study of Prostatic Urethral Lift (PUL): four year results. C Roehrborn, S Gange, N Shore, J Giddens, D Bolton, Bo Cowan, K McVary, P Chin, P Rashid and D Rukstalis. BJU International 117, 2016 Supplement 3, 19
  • A Prospective non randomized study to evaluate the safety and efficacy of the AROYO artificial urinary sphincter. P Chin, W Lynch, P Gilling, D Moon, P Rashid, S Mark, R Zachoval, O Haillot and M Oelke. BJU International 117, 2016 Supplement 3, 31.
  • Outcomes of acute scrotal exploration in a single centre: A 5 year experience. R Gendy, A Attwell-Heap and P Chin. BJU International 117, 2016 Supplement 3, 56
  • An audit of mechanical prostatic urethral lift in the Illawarra region. A Attwell-Heap, R Arianaygam, E Dally, P Kovac, T Skyring, R Rindani, S Murray and P Chin. BJU International 117, 2016 Supplement 3, 65
  • Do we need to tailor the prophylactic antibiotic regime for transrectal ultrasound guided biopsies of the prostate? A Ranasinghe, A Chung, T Skyring, R Rindani, P Kovac, D Gilbourd, E Dally, H Watt, K Nainge and P Chin. BJU International 115, 2015 Supplement 4, 8
  • BPH6 Trial: A multi-centre, prospective, randomized study of the Prostatic Urethral Lift vs Transurethral Resection of the Prostate (TURP). P Chin, J Sonsken, N Barber, C Gratzke, M Speakman, R Berges, U Wetterauer, D Greene, K-D Sievert, C Chapple and F Montorsi. BJU International 115, 2015 Supplement 4, 10 page 8
  • Prospective, randomized study of Prostatic Urethral lift (PUL) with three year results. P Rashid, P Chin, D Bolton, D Rukstalis, J Giddens, S Gange, N Shore, B Cowan, BT Brown, K McVary, A Te, S Gholami, W Moseley, R Tutrone, S Freedman,P Incze, KS Coffield, F Borges and C Roehrborn. BJU International 115, 2016 Supplement 4, 10
  • Two Year outcomes following crossover in the randomized controlled pivotal trial of the prostatic urethral lift. H Woo, P Rashid, A Cantwell, W Bogache, S Richardson, R Tutrone, J Barkin, J Fagelson and P Chin. BJU International 115, 2015 Supplement 4, 12


  • Fellow of the Royal Australasian College of Surgeons. 2000 – Current
  • Elected to Full Membership of the Urological Society of Australia and New Zealand. 2003-Current
  • Member of the American Urological Association. 2007 – Current
  • Member of the European Association of Urology. 2006 – Current
  • Member of Societe Internationale D’Urologie. 2009 – Current
  • Member of the Australian Medical Association. 2000 – Current
  • Member of the Urological Society Special Advisory Groups : Paediatric Urology, Female Urology and Urogenital Oncology. 2005 – Current
  • Consultant to the Scientific Advisory Board for Neotract. 2005 – Current

Other roles

  • Associate Professor, School of Medicine, University of Wollongong
  • Consultant Urologist, Wollongong Hospital, Illawarra Shoalhaven Local Health District
  • Chairman of the Lower Urinary Tract Symptoms (LUTS) Special Advisory Group to the Urological Society of Australia and New Zealand (USANZ)